SEC Form 4 · accession 0000899243-18-002313
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
PureTech Health LLC
10% Owner
Period of report
Jan 30, 2018
Accepted (ET)
Jan 30, 2018 · 6:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 30, 2018 | C | 7,680,700 | — | A | 9,567,063 | D | |
| Common Stock | Jan 30, 2018 | P | 233,333 | $15.00 | A | 9,800,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF2 | — | Jan 30, 2018 | C | 7,680,700 | D | — | — | Common Stock | 7,680,700 | 0 | D |
Explanation of responses
- F1Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
- F2All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1.2804-for-1 basis on January 30, 2018 and had no expiration date.